|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 491/052 | (2006.01) |
| A61K 31/436 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3820874 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19746252.6 |
| Date of filing the European patent application | 2019-07-11 | |
| (97) | Date of publication of the European application | 2021-05-19 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-30 |
| (46) | Date of publication of the claims translation | 2023-02-10 |
| (86) | Number | PCT/US2019/041342 |
| Date | 2019-07-11 |
| (87) | Number | WO 2020/014440 |
| Date | 2020-01-16 |
| (30) | Number | Date | Country code |
| 201862697100 P | 2018-07-12 | US | |
| 201962825172 P | 2019-03-28 | US |
| (72) |
COHEN, Jeffrey Daniel , US
SALL, Daniel Jon , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Selektyvūs estrogenų receptorių skaidytojai |
| SELECTIVE ESTROGEN RECEPTOR DEGRADERS |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 7 | 162.00 EUR |
| 2026-07-11 |